The SARS-CoV-2/Influenza A+B/RSV Antigen Combo Rapid Test (Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A, Influenza B and Respiratory Syncytial Virus(RSV) antigens in nasopharyngeal swab specimens from individuals with suspected SARS-CoV-2/Influenza/RSV infection in conjunction with clinical presentation and the results of other laboratory tests.
Fast (15minutes)
Simple Operation (Less Training Required)
Objective (Results Read by Analyzer)
High Accuracy
| Product features | Parameters |
| Format | Cassette |
| Specimen | Nasopharyngeal Swab |
| Certificate | CE |
| Reading Time | 15 minutes |
| Storage Temperature | 2-30°C |
| Sensitivity | SARS-CoV-2: 97.1%; Influenza A+B: Type A(95.0%), Type B(92.9%); RSV: 94.3% |
| Specificity | SARS-CoV-2: 99.1%; Influenza A+B: Type A(99.1%), Type B(99.1%); RSV: 96.2% |
| Accuracy | SARS-CoV-2: 98.2%; Influenza A+B: Type A(98.4%), Type B(98.1%); RSV: 95.9% |
| Cat. No. | Product | Specimen | Pack |
| ISIR-R535 | SARS-CoV-2/Influenza A+B/RSV Antigen Combo Rapid Test | Nasopharyngeal Swab |